ARCHIVES

Study Finds High-Risk Women Reluctant To Take Tamoxifen

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data

January 1, 1988

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

Lung Cancer Mortality Begins to decline Among Under 55 Group

April 6, 1990

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003